NasdaqGS - Delayed Quote
USD
Recursion Pharmaceuticals, Inc. (RXRX)
3.5200
+0.1300
(+3.83%)
At close: May 4 at 4:00:00 PM EDT
3.5397
+0.0197
(+0.56%)
Pre-Market: 6:34:31 AM EDT
Trade RXRX on Coinbase
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreLoading chart for RXRX
- Previous Close
3.3900 - Open
3.3950 - Bid 3.4900 x 11500
- Ask 3.5300 x 11500
- Day's Range
3.3900 - 3.5500 - 52 Week Range
2.8000 - 7.1800 - Volume
10,190,666 - Avg. Volume
14,613,066 - Market Cap (intraday)
1.868B - Beta (5Y Monthly) 1.05
- PE Ratio (TTM)
-- - EPS (TTM)
-1.5000 - Earnings Date May 6, 2026
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
6.57
Recent News: RXRX
View More
![[Latest] Global Generative AI in Chemical Market Size/Share Worth USD 12.84 Billion by 2035 at a 24.9% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)](https://s.yimg.com/uu/api/res/1.2/JDc8Q43tjkZAOscxTVa7kA--~B/Zmk9c3RyaW07aD02Mzt3PTg0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/0bec09301614ea6a3ee415db83086891.cf.webp)
Performance Overview: RXRX
Trailing total returns as of 5/4/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
RXRX
13.94%
S&P 500 (^GSPC)
5.19%
1-Year Return
RXRX
38.25%
S&P 500 (^GSPC)
26.63%
3-Year Return
RXRX
31.52%
S&P 500 (^GSPC)
77.31%
5-Year Return
RXRX
89.47%
S&P 500 (^GSPC)
72.90%
Earnings Trends: RXRX
View MoreAnalyst Insights: RXRX
View MoreStatistics: RXRX
View MoreValuation Measures
As of 5/1/2026
-
Market Cap
1.86B
-
Enterprise Value
1.20B
-
Trailing P/E
--
-
Forward P/E
--
-
PEG Ratio (5yr expected)
--
-
Price/Sales (ttm)
20.37
-
Price/Book (mrq)
1.58
-
Enterprise Value/Revenue
15.08
-
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
-
Profit Margin
0.00%
-
Return on Assets (ttm)
-27.72%
-
Return on Equity (ttm)
-59.54%
-
Revenue (ttm)
74.68M
-
Net Income Avi to Common (ttm)
-644.76M
-
Diluted EPS (ttm)
-1.5000
Balance Sheet and Cash Flow
-
Total Cash (mrq)
743.29M
-
Total Debt/Equity (mrq)
6.89%
-
Levered Free Cash Flow (ttm)
-208.52M
Compare To: RXRX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Company Insights: RXRX
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Learn more
Dividend Score
The distribution of earnings a company pays back to its shareholders based off the company’s profits. Usually paid out on a quarterly basis in the form of cash or additional stocks.
Hiring Score
A company’s hiring trends in key indicators can indicate how well the company is doing in terms of growing the company and where they are currently prioritizing.
Insider Sentiment Score
Vicker’s Insider Sentiment provides insights into trades made by insiders. This can be used to gain valuable insights and as a reflection of the prospect of the company based on insider trading.
